Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Enveric Biosciences: Novel strategies to treat side effects of cancer and cancer treatment

Joseph Tucker • 24 Nov 2021
General

Joseph Tucker, PhD, CEO of Enveric Biosciences, Naples, FL, explains how the company aims to tackle the untreated side effects of cancer and cancer treatment, from which many patients suffer. The key avenues of research include cannabinoids for radiation dermatitis and psychedelcis for cancer-related distress.

Disclosures

Forward-Looking Statements

This video presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. A discussion of these factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.

More from Joseph Tucker

2:59
Cannabinoids for radiation dermatitis
Joseph Tucker • 24 Nov 2021
2:54
Psychedelics for cancer-related distress
Joseph Tucker • 24 Nov 2021
1:48
PsyAI artificial intelligence system
Joseph Tucker • 24 Nov 2021

Related Videos

2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
0:48
TAPUR: commercially available targeted therapies in solid tumors
Deepti Behl • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals